failur
passiv
transfer
common
problem
calv
destin
veal
product
present
unknown
whether
risk
respiratori
diseas
brd
neonat
calf
diarrhea
ncd
veal
herd
associ
total
immunoglobulin
ig
andor
serostatu
respiratori
pathogen
measur
arriv
therefor
first
object
prospect
longitudin
cohort
studi
determin
associ
serum
protein
fraction
determin
routin
electrophoresi
total
protein
albumin
globulin
betaglobulin
ig
arriv
brd
ncd
first
week
product
cycl
second
object
determin
whether
serostatu
seropositiveseroneg
seven
respiratori
pathogen
bovin
respiratori
syncyti
viru
brsv
bovin
coronaviru
bcv
bovin
bovin
viral
diarrhea
viru
mannheimia
haemolytica
mycoplasma
bovi
arriv
serum
sampl
could
associ
risk
brd
third
object
determin
electrophoresi
protein
respiratori
serostatus
associ
averag
daili
gain
adg
studi
period
studi
popul
consist
veal
calv
hous
singl
airspac
studi
period
end
day
post
arriv
brd
incid
judg
high
postpon
group
treatment
cox
regress
model
use
determin
effect
studi
protein
fraction
antibodi
time
brd
ncd
occurr
effect
studi
predictor
adg
determin
linear
regress
calv
ig
level
gl
increas
brd
hazard
hazard
ratio
hr
confid
interv
ci
ncd
posit
associ
globulin
concentr
calv
neg
serostatu
bcv
hr
ci
brsv
hr
ci
increas
brd
hazard
averag
daili
gain
adg
kgday
sd
relat
occurr
brd
ncd
calv
ig
gl
increas
level
globulin
show
decreas
adg
studi
show
import
provid
suffici
colostrum
veal
calv
potenti
benefit
presenc
bcv
brsv
antibodi
arriv
reduc
brd
hazard
first
week
recent
year
high
level
antimicrobi
multi
resist
detect
pathogen
commens
indic
zoonot
bacteria
european
north
american
veal
sector
catri
et
al
di
labio
et
al
cook
et
al
maran
emerg
livestock
associ
methicillin
resist
staphylococcu
aureu
extend
betalactamas
esbl
enterobacteriacea
food
anim
initi
public
discuss
western
europ
sever
increas
pressur
veterinari
antimicrobi
use
graveland
et
al
vandendriessch
et
al
antimicrobi
resist
select
predominantli
driven
antimicrobi
use
bosman
et
al
therefor
intens
antimicrobi
use
veal
sector
http
elsevi
bv
right
reserv
urgent
need
reduc
public
health
polit
econom
reason
maran
maran
pardon
et
al
select
calv
base
diseas
risk
subsequ
target
metaphylact
antimicrobi
treatment
toward
high
risk
batch
one
potenti
strategi
ration
reduc
antimicrobi
consumpt
calf
select
paramet
includ
age
arriv
bodi
weight
infect
statu
bovin
viral
diarrhea
viru
bvdv
presenc
diseas
umbil
infect
bovin
respiratori
diseas
brd
neonat
calf
diarrhea
ncd
wilson
et
al
suffici
uptak
colostrum
gulliksen
et
al
brscic
et
al
pardon
et
al
failur
passiv
transfer
fpt
show
preval
rang
unit
state
mcdonough
et
al
wilson
et
al
stilwel
carvalho
also
belgium
averag
veal
calv
fpt
assum
immunoglobulin
g
igg
level
lower
gl
upon
arriv
indic
colostr
defici
pardon
crucial
role
suffici
igg
uptak
protect
calv
brd
ncd
mortal
evidenc
multipl
occas
postema
mol
furmanfratczak
et
al
stilwel
carvalho
effect
shown
last
month
brd
virtala
et
al
evalu
colostrum
uptak
sever
test
valid
healthi
anim
age
categori
day
weaver
et
al
although
cheap
indirect
screen
test
determin
total
protein
tp
refractomet
perform
reason
well
direct
determin
immunoglobulin
ig
igg
gener
specif
weaver
et
al
calv
sampl
within
week
birth
cut
valu
igg
gl
gener
accept
determin
fpt
link
diseas
occurr
although
studi
report
higher
cutoff
particular
situat
waldner
rosengren
furmanfratczak
et
al
stilwel
carvalho
contrast
current
unknown
whether
ig
level
measur
age
arriv
veal
calv
week
old
use
predictor
brd
ncd
veal
sector
would
interest
identifi
test
calv
upon
arriv
individu
calv
requir
adapt
treatment
herd
origin
insuffici
colostrum
manag
therefor
first
object
present
studi
determin
whether
ig
protein
determin
routin
electrophoresi
measur
arriv
associ
occurr
brd
ncd
veal
calv
first
week
arriv
therefor
potenti
use
risk
classif
calv
arriv
hypothesi
calv
low
tp
ig
would
substanti
higher
risk
acquir
brd
ncd
gain
insight
antibodi
might
play
protect
role
brd
second
object
determin
associ
serostatu
respiratori
pathogen
measur
arriv
brd
occurr
sinc
earlier
studi
demonstr
direct
effect
fpt
averag
daili
gain
adg
first
month
life
robison
et
al
virtala
et
al
third
object
determin
studi
serum
paramet
electrophoresi
protein
fraction
respiratori
antibodi
diseas
associ
adg
studi
period
studi
design
prospect
longitudin
cohort
studi
studi
protocol
review
approv
ethic
committe
faculti
veterinari
medicin
ghent
univers
licens
ec
studi
carri
typic
starter
veal
farm
locat
south
netherland
januari
type
oper
special
rais
calv
week
transport
finish
herd
sole
criterion
farm
select
willing
cooper
studi
calv
hous
slat
floor
airspac
first
week
calv
hous
individu
metal
frame
pen
floor
surfac
air
volum
per
calf
period
metal
framework
remov
anim
kept
group
anim
remain
rais
period
studi
compart
physic
isol
calf
unit
present
farm
full
wall
separ
ventil
system
stabl
mechan
ventil
refresh
rate
temperatur
maintain
c
calv
fed
crude
protein
cp
crude
fat
cf
milk
replac
mr
diet
dri
mater
base
amount
mr
gradual
increas
l
g
powderl
morn
even
day
twice
daili
l
gl
end
studi
day
milk
individu
provid
drink
bucket
addit
mr
calv
receiv
chop
straw
gday
day
studi
period
starter
concentr
gday
cp
cf
studi
group
vaccin
receiv
antimicrobi
group
treatment
arriv
sampl
size
calcul
detect
differ
brd
incid
calv
less
g
igl
vs
confid
power
winepiscop
thrusfield
et
al
twotail
test
anim
within
group
need
practic
reason
account
mortal
studi
group
consist
anim
present
airspac
anim
ethic
econom
reason
agre
beforehand
studi
would
finish
respons
veterinarian
deem
necessari
initi
group
treatment
although
object
criteria
set
usual
done
anim
ill
day
occur
high
predict
week
pardon
et
al
pardon
et
al
casu
studi
period
last
arriv
day
arriv
calv
clinic
examin
health
statu
monitor
twice
daili
morn
even
durat
studi
veterinarian
case
definit
ncd
presenc
diarrhea
partial
anorexia
depress
brd
case
definit
base
score
system
use
follow
symptom
depress
cough
rectal
temperatur
nasal
discharg
tabl
anim
score
consid
case
omphal
defin
presenc
pain
umbil
swell
arriv
anim
diagnos
omphal
treat
iu
benzylpenicillin
dopharma
raamsdonksv
netherland
im
daili
day
ncd
treat
sulphadoxintrimethoprim
dofatrimject
dopharma
raamdonksv
netherland
mgkg
im
sid
day
meloxicam
novem
boehring
ingelheim
vetmedica
gmbh
ingelheimrhein
germani
mgkg
im
sid
day
case
respons
treatment
ncd
case
treat
mgkg
gentamicin
im
gentaject
dopharma
raamsdonksv
nederland
brd
case
treat
singl
inject
tildipirosin
mgkg
subcutan
zuprevo
merck
usa
meloxicam
drug
use
studi
period
quantifi
standard
daili
dose
methodolog
describ
previous
pardon
et
al
anim
defin
daili
dose
add
antimicrobi
drug
mention
deriv
belgian
veterinari
repertori
bcfi
combin
product
eg
sulphonamid
trimethoprim
administr
count
two
dose
long
act
product
long
act
factor
use
tildipirosin
recommend
manufactur
arriv
end
studi
period
day
calv
weigh
electron
balanc
rinstrum
kg
precis
blood
taken
jugular
vein
g
needl
vacutain
system
venoject
terumo
belgium
arriv
end
studi
period
blood
centrifug
g
min
approxim
c
store
c
laboratori
analys
laboratori
analysi
determin
etiolog
ncd
antigen
elisa
detect
cyptosporidium
parvum
bovin
coronaviru
bcv
bovin
rotaviru
enterotox
escherichia
coli
tetrastrip
bio
k
biox
jemel
belgium
conduct
fresh
fecal
sampl
ncd
case
determin
circul
brd
pathogen
serostatu
arriv
identifi
circul
brd
pathogen
studi
period
antibodi
elisa
bovin
respiratori
syncyti
viru
brsv
parainfluenzaviru
bovin
herpesviru
bvdv
mycoplasma
bovi
elisa
respiratori
kit
biok
biox
jemel
belgium
bcv
biok
biox
jemel
belgium
mannheimia
haemolytica
biok
biox
jemel
belgium
perform
pair
sampl
determin
seroconvers
sampl
anim
test
plate
determin
seroconvers
serostatu
arriv
posit
neg
accord
manufactur
guidelin
determin
amount
albumin
globulin
globulin
betaglobulin
bg
gammaglobulin
immunoglobulin
ig
arriv
serum
sampl
electrophoresi
conduct
solid
phase
extract
capillari
sebia
franc
accredit
laboratori
zoolyx
aalst
belgium
use
optim
set
anim
sampl
tp
measur
colorimetr
autom
biochemistri
analyz
coba
roch
belgium
qualiti
control
previous
run
within
qualiti
assur
specif
data
analyz
sa
sa
institut
inc
cari
nc
unit
analysi
individu
calf
work
hypothesi
total
protein
ig
predictor
brd
ncd
veal
calv
wherea
protein
fraction
determin
routin
electrophoresi
albumin
ag
bg
surviv
analysi
use
assess
associ
serum
protein
fraction
tp
albumin
bg
ig
time
brd
ncd
diagnosi
two
cox
proport
hazard
model
proc
phreg
built
respect
ncd
brd
outcom
variabl
use
breslow
tie
model
predictor
protein
fraction
tp
albumin
bg
ig
bodi
weight
arriv
potenti
confound
evalu
calv
arriv
three
batch
order
correct
cluster
arriv
batch
ad
fix
effect
predictor
test
univari
continu
categor
base
quartil
signific
effect
note
one
quartil
binari
variabl
construct
time
arriv
occurr
ncd
brd
defin
surviv
time
diseas
either
brd
ncd
event
censor
occur
day
studi
end
anim
remain
undiseas
model
build
procedur
follow
first
predictor
test
univari
p
select
multivari
model
final
multivari
model
built
stepwis
backward
exclud
nonsignific
variabl
next
biolog
relev
twoway
interact
signific
fix
effect
test
signific
set
p
p
consid
trend
wald
test
use
assess
paramet
estim
signific
visual
inspect
logcumul
hazard
plot
andor
schoenfeld
residu
schoenfeld
construct
timevari
covari
use
evalu
proport
hazard
assumpt
signific
protein
fraction
relationship
studi
diseas
visual
mean
kaplanmei
surviv
curv
proc
lifetest
logrank
test
perform
practic
recommend
regard
threshold
identifi
futur
problemat
anim
base
signific
paramet
desir
therefor
signific
paramet
primari
interest
ig
receiv
oper
characterist
roc
curv
creat
determin
optim
ig
cutoff
valu
brd
ncd
subsequ
categor
variabl
creat
variabl
base
upon
cutoff
replac
origin
continu
variabl
hypothesi
anim
seroneg
respiratori
pathogen
would
experi
increas
brd
hazard
studi
period
cox
proport
hazard
model
built
brd
event
variabl
time
arriv
occurr
brd
surviv
time
case
experi
brd
day
right
censor
predictor
test
n
serostatu
brsv
bcv
bvdv
haemolytica
bovi
bodi
weight
arriv
potenti
confound
arriv
batch
ad
fix
effect
adjust
cluster
model
build
procedur
evalu
visual
mention
section
work
hypothesi
low
tp
ig
associ
reduc
adg
similarli
reduc
adg
seroneg
anim
respiratori
pathogen
expect
normal
distribut
adg
check
qq
plot
kolmogorovsmirnov
test
linear
mix
model
proc
mix
arriv
batch
random
effect
account
cluster
within
batch
use
covari
structur
specifi
varianc
compon
effect
predictor
evalu
serum
protein
fraction
tp
albumin
bg
ig
serostatus
respiratori
pathogen
brsv
bvdv
bcv
haemolytica
bovi
diseas
ncd
brd
first
predictor
test
univari
associ
adg
continu
predictor
ad
continu
quartil
predictor
p
maintain
multivari
model
built
stepwis
backward
exclud
nonsignific
variabl
pearson
spearman
rho
correl
calcul
signific
predictor
correl
higher
signific
variabl
retain
multivari
model
relationship
signific
categor
predictor
explor
univari
logist
regress
proc
logist
final
model
pairwis
comparison
categor
predictor
made
bonferroni
adjust
multipl
comparison
biolog
relev
twoway
interact
signific
fix
effect
test
signific
set
p
p
consid
trend
model
fit
assumpt
evalu
check
normal
distribut
residu
calv
arriv
day
three
batch
calv
largest
batch
origin
germani
two
tabl
serostatu
arriv
seroconvers
rate
respiratori
pathogen
veal
calv
first
three
week
arriv
finish
unit
percentag
seroposit
arriv
netherland
calv
male
mean
arriv
age
day
standard
deviat
sd
rang
r
day
mean
arriv
weight
kg
sd
r
arriv
calv
omphal
one
diarrhea
fig
number
new
case
ncd
brd
studi
period
present
diarrhea
occur
first
day
cumul
incid
ci
daili
brd
incid
remain
first
day
day
ci
accumul
day
brd
outbreak
occur
involv
calv
studi
stop
day
anim
receiv
oral
group
treatment
mgkg
tilmicosin
phosphat
pulmotil
ac
elanco
indianapoli
usa
blur
diseas
detect
total
calv
develop
brd
studi
period
relaps
mean
score
brd
case
sd
r
rectal
temperatur
c
treatment
regard
ncd
case
c
parvum
detect
fecal
sampl
n
frequent
respiratori
pathogen
circul
studi
period
bovi
bcv
bvdv
tabl
one
calf
die
studi
necropsi
demonstr
enter
dehydr
low
bodi
condit
studi
period
calf
receiv
averag
add
add
respiratori
diseas
add
ncd
add
umbil
infect
adg
studi
period
kgday
sd
r
studi
popul
mean
total
ig
concentr
gl
sd
r
calv
ig
level
gl
tabl
mean
valu
serum
protein
fraction
calv
without
ncd
brd
display
roc
analysi
ig
demonstr
optim
cutoff
area
curv
sensit
specif
predict
whether
calf
would
develop
brd
gl
subsequ
ig
ad
model
binari
variabl
base
cut
factor
univari
associ
p
brd
hazard
bodi
weight
arriv
p
ig
p
final
model
ig
remain
significantli
associ
time
occurr
brd
tabl
fig
ncd
signific
associ
level
globulin
present
everi
increas
globulin
gl
ncd
hazard
increas
tabl
arriv
batch
effect
signific
calv
smallest
batch
netherland
experienc
significantli
higher
ncd
risk
compar
batch
antibodi
elisa
determin
serostatu
respiratori
pathogen
studi
interpret
calv
leav
calv
analysi
tabl
show
brd
incid
accord
serostatu
respiratori
pathogen
arriv
univari
associ
predictor
time
brd
occurr
withheld
multivari
model
brsv
p
bcv
p
p
bovi
p
serostatu
bcv
brsv
remain
signific
multivari
model
p
descript
adg
accord
diseas
statu
provid
tabl
factor
univari
associ
adg
albumin
p
p
p
bcv
p
p
brsv
p
p
final
multivari
tabl
calv
ig
level
gl
arriv
grew
averag
gday
ci
less
everi
increas
globulin
gl
adg
decreas
gday
ci
contrast
previou
studi
diseas
occurr
veal
calv
postema
mol
postema
et
al
brscic
et
al
pardon
diseas
detect
present
studi
blur
routin
administr
antimicrobi
arriv
given
intens
daili
monitor
surpris
find
much
higher
brd
incid
first
three
week
compar
previous
report
figur
white
veal
calv
complet
product
cycl
brscic
et
al
pardon
et
al
also
ncd
cumul
incid
present
studi
three
time
higher
previous
report
pardon
et
al
observ
confirm
diseas
incid
mask
practic
due
administr
antimicrobi
group
treatment
given
similar
preval
fpt
present
studi
compar
previou
work
europ
us
systemat
presenc
respiratori
pathogen
veal
herd
wilson
et
al
pardon
et
al
pardon
studi
like
good
extern
valid
veal
sector
previou
studi
matern
ig
calv
radial
immunodiffus
mention
gold
standard
assay
igg
determin
test
expens
contrast
electrophoresi
refractometri
use
larg
scale
veal
industri
therefor
author
opt
use
serum
electrophoresi
determin
concentr
ig
test
use
routin
mani
veterinari
diagnost
laboratori
europ
age
week
ig
fraction
consist
vast
major
igg
therefor
result
obtain
electrophoresi
highli
similar
test
determin
igg
burton
et
al
main
find
present
studi
clear
relat
ig
measur
arriv
time
brd
occurr
veal
farm
observ
contrast
previou
studi
could
evid
associ
postema
mol
postema
et
al
like
explan
differ
suboptim
diseas
express
thu
detect
administr
antimicrobi
group
treatment
previou
studi
wherea
present
studi
optim
cutoff
predict
brd
veal
calv
gl
previou
studi
use
gl
cut
matern
antibodi
quickli
declin
birth
normal
igg
rang
healthi
calv
receiv
enough
colostrum
report
gl
age
week
hassig
et
al
therefor
illog
calv
fpt
level
gl
age
week
calv
ig
gl
substanti
higher
brd
hazard
accord
berg
et
al
anim
welfar
might
compromis
antimicrobi
administ
group
arriv
howev
sinc
calv
involv
group
treatment
compli
prudent
use
antimicrobi
also
exampl
netherland
belgium
prophylact
administr
antimicrobi
forbidden
strongli
discourag
respect
present
practic
applic
ig
determin
veal
sector
regular
screen
calv
purchas
order
identifi
herd
origin
insuffici
colostrum
manag
observ
associ
ig
level
measur
age
week
brd
also
interest
convent
dairi
beef
farm
enlarg
window
calv
test
fpt
third
week
life
facilit
routin
check
fpt
herd
context
import
emphas
measur
tp
cheapest
option
longer
use
age
week
contrast
first
day
life
calv
age
week
albumin
concentr
increas
decreas
proport
ig
tp
might
explain
absenc
signific
associ
tp
diseas
mohri
et
al
also
wellknown
influenc
hydrat
statu
protein
loss
variou
caus
eg
diarrhea
tp
level
weaver
et
al
might
play
role
anim
alreadi
diseas
test
shortli
thereaft
find
similar
relationship
ig
ncd
observ
brd
like
reason
c
parvum
identifi
colostr
antibodi
confer
protect
also
previou
studi
c
parvum
frequent
isol
pathogen
veal
calf
diarrhea
mcdonough
et
al
hoet
et
al
howev
signific
associ
ncd
increas
level
globulin
ncd
alreadi
present
arriv
develop
shortli
thereaft
therefor
sever
anim
might
alreadi
inflam
intestin
sinc
globulin
fraction
contain
acut
phase
protein
haptoglobulin
ceruloplasmin
alreadi
ongo
inflamm
like
explain
observ
associ
also
observ
calv
seroneg
bcv
brsv
increas
brd
hazard
might
signifi
among
virus
bcv
brsv
contribut
brd
first
week
arriv
hand
observ
relationship
might
due
fact
virus
preval
pathogen
studi
group
clarifi
benefit
presenc
bcv
brsv
antibodi
arriv
unlik
cohort
anoth
viru
predomin
seroneg
statu
particular
viru
risk
factor
nevertheless
base
upon
present
observ
provid
suffici
specif
immun
respiratori
virus
transport
veal
farm
either
vaccin
colostrum
uptak
might
interest
strategi
reduc
risk
brd
veal
calv
adg
one
primari
econom
outcom
veal
sector
averag
adg
kgday
line
expect
growth
diet
mcal
day
ambient
temperatur
c
nrc
wellknown
neg
effect
brd
ncd
adg
wittum
et
al
rerat
et
al
pardon
et
al
observ
present
studi
possibl
intens
monitor
earli
treatment
allevi
inflamm
brd
viral
origin
lead
mild
inflamm
associ
low
ig
adg
observ
author
dairi
calv
seen
veal
calv
later
age
robison
et
al
virtala
et
al
berg
et
al
lower
adg
calv
higher
globulin
concentr
like
reflect
increas
protein
calor
cost
ongo
inflamm
barn
et
al
conclus
clear
effect
ig
concentr
arriv
brd
adg
first
week
demonstr
veal
calv
possibl
applic
screen
veal
calv
arriv
might
identif
herd
origin
poor
colostrum
manag
classif
calv
accord
brd
risk
target
antimicrobi
treatment
practic
use
ig
cutoff
gl
recommend
protein
fraction
determin
routin
electrophoresi
includ
tp
display
associ
direct
practic
use
secondli
calv
seroneg
bcv
brsv
arriv
increas
brd
risk
first
week
product
cycl
therefor
assur
seroposit
statu
virus
either
vaccin
farm
origin
provis
colostrum
vaccin
cow
might
appropri
approach
reduc
brd
risk
subsequ
prudent
antimicrobi
use
veal
calf
sector
none
author
paper
financi
person
relationship
peopl
organ
could
inappropri
influenc
bia
content
paper
studi
support
fund
first
author
institut
